Business Daily.
.
A+ R A-

PLATFORM Trial Shows HeartFlow FFRCT Analysis Significantly Decreases Unnecessary Invasive Diagnostic Testing for Coronary Artery Disease

E-mail Print PDF
LONDON--(BUSINESS WIRE)--A technology developed by HeartFlow, Inc. has been shown in a study to significantly reduce the use of invasive catheterization in patients with suspected coronary artery disease.

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media